Skip to content
Convokast

Burden of Proof: Luigi Mangione artwork

How to get on Burden of Proof: Luigi Mangione

Published by ABC News

Luigi Mangione will soon be in a Manhattan courtroom, standing trial for the murder of United Healthcare CEO Brian Thompson, who was shot dead on a New York City sidewalk in December 2024. In this five-part series, ABC News Legal Analyst Brian Buckmire examines a case that has captivated the country – and explores how Brian Thompson’s mur…

Episodes34
CadenceWeekly
Last episodeAug 2026
Takes guestsYes
How to pitch it

Burden of Proof: Luigi Mangione runs an interview format and publishes roughly every 4 days. Signals we read: guest name leads the title; interview language in episodes. Pitch a specific episode idea rather than a description of yourself, reference an episode you have actually heard, and lead with one checkable proof point. Shows at this cadence typically book two to six weeks out.

guest name leads the titleinterview language in episodes

Burden of Proof: Luigi Mangione FAQ

Does the Burden of Proof: Luigi Mangione podcast accept guest pitches?

Burden of Proof: Luigi Mangione runs an interview format, which means guest pitches are realistic. Whether a specific pitch lands still depends on topic fit and how the show is approached.

What does the Burden of Proof: Luigi Mangione podcast cover?

Luigi Mangione will soon be in a Manhattan courtroom, standing trial for the murder of United Healthcare CEO Brian Thompson, who was shot dead on a New York City sidewalk in December 2024. In this five-part series, ABC News Legal Analyst Brian Buckmire examines a case that has captivated the country – and explores how Brian Thompson’s murder affected the conversation about healthcare in America. Subscribe to 20/20 True Crime+ for ad-free listening, early access to new series,

Next step

We pitch shows like this every week.

Flat $499 a month, one guaranteed placement minimum, and you approve every show before we pitch it.

Book a discovery call

Free 20-minute call. If we are not a fit, we will say so.